Mitral/Tricuspid Valvular Disease - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

文章摘要

Association of Effective Regurgitation Orifice Area to Left Ventricular End-Diastolic Volume Ratio With Transcatheter Mitral Valve Repair OutcomesA Secondary Analysis of the COAPT Trial
Outcomes of TTVI in Patients With Pacemaker or Defibrillator Leads: Data From the TriValve Registry
Patient and Hospital Characteristics of Mitral Valve Surgery in the United States
Functional Mitral Regurgitation Outcome and Grading in Heart Failure With Reduced Ejection Fraction
Regurgitant Volume/Left Ventricular End-Diastolic Volume Ratio: Prognostic Value in Patients With Secondary Mitral Regurgitation
Attenuated Mitral Leaflet Enlargement Contributes to Functional Mitral Regurgitation After Myocardial Infarction
Prevalence and clinical implications of valvular calcification on coronary computed tomography angiography
A Score to Assess Mortality After Percutaneous Mitral Valve Repair
Thrombotic Risk and Antithrombotic Strategies After Transcatheter Mitral Valve Replacement
Impact of Transcatheter Mitral Valve Repair on Preprocedural and Postprocedural Hospitalization Rates

Clinical Trial

2019 May 14;40(19):1553-1562.

JOURNAL：Eur Heart J.

Dabigatran dual therapy with ticagrelor or clopidogrel after percutaneous coronary intervention in atrial fibrillation patients with or without acute coronary syndrome: a subgroup analysis from the RE-DUAL PCI trial

Oldgren J, Steg PG, Hohnloser SH et al.

18128

Keywords: atrial fibrillation with PCI history; dabigatran with P2Y12 inhibitor vs warfarin with P2Y12 inhibitor and aspirin; major bleeding

FULL TEXT PDF